Skip to main content
. 2014 Aug 1;5(8):628–632. doi: 10.7150/jca.9409

Table 1.

Patient Characteristics.

Valid Cases N (%)
No of patients 22
Male:Female 11 : 11 50 : 50
Median Age, y, (Range) 65 (35-77)
Performance Status WHO
0, 1, 2, 3, 4 6 / 10 / 3 / 2 / 1 27.0 / 45.5 / 14.0 / 9.0 / 4.5
Primary Tumor
Pancreas 2 9
Esophagus/Cardia 8 36
Small Intestine 2 9
Colon 1 5
CUP (Cancer of unknown primary) 9 41
Chromogranin A Immunohistochemistry
Strongly positive / Positive/ Weakly positive/ Negative / Not Done 4 / 8 / 7 / 1 / 2 18 / 36 / 32 / 5 / 9
Synaptophysin Immunohistochemistry
Strongly positive / Positive/ Weakly positive/ Negative 11 / 9 / 1 / 1 50 .0 / 41.0 / 4.5 / 4.5
Somatostatin Receptor Scintigraphy
Strongly positive (>liver uptake) 3 14.5
Weakly Positive (<liver uptake) 3 14.5
Negative 10 46.0
Not done 6 27.0
Ki-67
Median, %, (Range) 95 (25-100)
≥ 55% 17 77
< 55% 5 23
Site of metastases
Liver 11
Lymph nodes 19
Brain 3
Bone 5
Pleural 1
Lung 3
Skin 2
Breast 1
Peritoneal, Retroperitoneal 4
No. of metastatic sites
1 7 32
2 7 32
≥3 8 36